Retrovirology

official impact factor 5.24

Open Access Highly Access Research

MDM2 is a novel E3 ligase for HIV-1 Vif

Taisuke Izumi1, Akifumi Takaori-Kondo1*, Kotaro Shirakawa1,2, Hiroaki Higashitsuji3, Katsuhiko Itoh3, Katsuhiro Io1, Masashi Matsui1, Kazuhiro Iwai4,5, Hiroshi Kondoh6, Toshihiro Sato7, Mitsunori Tomonaga7, Satoru Ikeda7, Hirofumi Akari8, Yoshio Koyanagi9, Jun Fujita3 and Takashi Uchiyama1

Author Affiliations

1 Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawaracho, Sakyo-ku, Kyoto 606-8507, Japan

2 Japanese Foundation for AIDS Prevention, 1-3-12 Misaki-cho, Chiyoda-ku, Tokyo 101-0061, Japan

3 Department of Clinical Molecular Biology, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawaracho, Sakyo-ku, Kyoto 606-8507, Japan

4 Department of Molecular Cell Biology, Graduate School of Medicine, Osaka City University, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan

5 CREST, Japan Science Technology Corporation, Kawaguchi, Saitama 332-0012, Japan

6 Department of Geriatric Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawaracho, Sakyo-ku, Kyoto 606-8507, Japan

7 Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1 Murasaki-cho, Takatsuki, Osaka 569-1125, Japan

8 Laboratory of Disease Control, Tukuba Primate Research Center, National Institute of Biomedical Innovation, Hachimandai-1, Tsukuba, Ibaraki 305-0843, Japan

9 Laboratory of Viral Pathgenesis, Institute for Virus Research, Kyoto University, 53 Shogoin-Kawaracho, Sakyo-ku, Kyoto 606-8507, Japan

For all author emails, please log on.

Retrovirology 2009, 6:1 doi:10.1186/1742-4690-6-1

Published: 7 January 2009

Additional files

Additional file 1:

Supplementary figure 1 – the stability of Vif protein in p53-/- MEF and p53-/-MDM2-/- MEF cells. MEF cells were transfected with pDON/Vif or pcDNA3/HA-A3G. Twenty-two hours after transfection, the cells were treated with cycloheximide (CHX) for the indicated times, and cell lysates were subjected to immunoblotting with the indicated Abs.

Format: PDF Size: 73KB Download file

This file can be viewed with: Adobe Acrobat Reader

Open Data

Additional file 2:

Supplementary figure 2 – immunopurified MDM2 induced the polyubiquitination of Vif in vitro. (A) MDM2 as well as Cul5 induced the polyubiquitination of Vif. HEK293T cells were transfected with expression vectors for His-MDM2 and His-Cul5. His-tagged proteins were purified using Ni-NTA agarose and subjected to in vitro ubiquitination assays as described in a legend to Fig. 4A. Reactions were subjected to immunoblotting with anti-Vif Ab. Arrows indicate GST-Ub-conjugated Vif. Asterisks indicate non-specific bands associated with GST-Vif protein recognized by anti-Vif Ab, as they are seen in lanes 1 and 3. (B) MDM2 induced the polyubiquitination of Vif Wt but not that of Δ22 that was defective for binding MDM2. Filled asterisks indicate non-specific bands associated with GST-Vif protein, while white asterisks indicate those associated with GST-Vif Δ22.

Format: PDF Size: 62KB Download file

This file can be viewed with: Adobe Acrobat Reader

Open Data

Additional file 3:

Supplementary figure 3 – the overexpression of MDM2 inhibited HIV-1 replication in the presence of A3F. Single round infection assays were performed in the presence or absence of A3F as described in a legend to Fig. 5A. Values are presented as averages of more than 3 independent experiments.

Format: PDF Size: 50KB Download file

This file can be viewed with: Adobe Acrobat Reader

Open Data